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Abstract
Background: The cost of mosquito repellents in Latin America has discouraged their wider use
among the poor. To address this problem, a low-cost repellent was developed that reduces the
level of expensive repellent actives by combining them with inexpensive fixatives that appear to
slow repellent evaporation. The chosen actives were a mixture of para-menthane-diol (PMD) and
lemongrass oil (LG).
Methods: To test the efficacy of the repellent, field trials were staged in Guatemala and Peru.
Repellent efficacy was determined by human-landing catches on volunteers who wore the
experimental repellents, control, or 15% DEET. The studies were conducted using a balanced Latin
Square design with volunteers, treatments, and locations rotated each night.
Results: In Guatemala, collections were performed for two hours, commencing three hours after
repellent application. The repellent provided >98% protection for five hours after application, with
a biting pressure of >100 landings per person/hour. The 15% DEET control provided lower
protection at 92% (p < 0.0001). In Peru, collections were performed for four hours, commencing
two hours after repellent application. The PMD/LG repellent provided 95% protection for six
hours after application with a biting pressure of >46 landings per person/hour. The 20% DEET
control provided significantly lower protection at 64% (p < 0.0001).
Conclusion: In both locations, the PMD/LG repellent provided excellent protection up to six
hours after application against a wide range of disease vectors including Anopheles darlingi. The
addition of fixatives to the repellent extended its longevity while enhancing efficacy and significantly
reducing its cost to malaria-endemic communities.
Background
In 2005, the WHO reported that 41% of malaria cases
occur outside of Africa [1]. This marked a significant
increase over their 2001 estimate of 13.6% [2] and reflects
a growing awareness of the malaria problem beyond
Africa. Greater recognition of this should encourage
increased research on malaria vector control in other areas
of the globe, an important consideration, as vectors in
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these regions generally exhibit behavior patterns that
make them less susceptible to control measures shown to
be effective in Africa, such as insecticide treated bednets
(ITNs) and indoor residual spraying (IRS).
These behaviors include tendencies to [i] outdoor resting
e.g. Anopheles darlingi [3] and Anopheles dirus [4]; ii) out-
door feeding e.g. Anopheles minimus [4], An. darlingi[3],
and Anopheles sinensis [4]; and iii) significant feeding activ-
ity during early evening e.g. Anopheles albimanus [5],
Anopheles nuneztovari [5], Anopheles farauti No.2 [6] and
An. darlingi [7]. A study for implementing ITNs in four
Latin America countries showed that 25% of An. albi-
manus  in Nicaragua, 28% of Anopheles punctimacula in
Ecuador, 57% of An. albimanus in Peru, and 30% of An.
nuneztovari, also in Peru, fed before 9:00 pm, when people
are still active and often still outdoors [8]. More recently,
a case-control study in Colombia [9] showed that ITNs
provided only 50% reduction in malaria. The authors
attributed this to bites received when people were not
sleeping under their nets. Even in areas where ITNs are
considered to be highly effective malaria control tools, it
appears that their introduction may have caused behavio-
ral shifts among malaria vectors, with outdoor and early
evening feeding becoming more frequent among them.
In such conditions, ITNs may be usefully supplemented
by an effective insect repellent [10,11]. A recent house-
hold randomized trial in Pakistan [12] confirmed that the
widespread provision of a repellent soap incorporating
DEET and permethrin can reduce the risk of malaria by
>50%. Moreover, an unpublished clinical trial in the
Bolivian Amazon [13], with a 30% para-menthane-diol
(PMD) formulation, showed an 80% reduction in P. vivax
in those using repellent and ITNs, compared to an ITN
only group.
In countries burdened with malaria, nearly all families
affected by the disease face severe economic pressure from
loss of income and treatment costs. In fact, for the poorest
families in Latin America these indirect costs may repre-
sent as much as 20% of annual household income
[14,15]. In response to these conditions, a low-cost repel-
lent lotion (LCR) was developed by S.T. Darling for distri-
bution to malaria-endemic communities in the Americas.
This plant-based formulation (patent pending) incorpo-
rates two principal active ingredients: para-menthane-diol
(PMD) and lemongrass oil (LG). PMD is derived from
pine extractives or from lemon eucalyptus (Corymbia citri-
odora), a tree that is grown commercially in Latin America
and China. PMD is a highly effective, broad-spectrum
insect repellent [16-18] that has proven to lower malaria
incidence where malaria transmission is maintained by
An. darlingi [13]. Lemongrass oil, a distillate of Cymbopo-
gon citratus or Cymbopogon flexuosus leaves, is traditionally
used in many parts of the Americas to repel mosquitoes
[19] and it is repellent to An. darlingi and other disease
vectors (Moore et al., in preparation). To lower the cost of
the repellent and maintain its efficacy, the PMD and LG
actives were combined with some low-cost ingredients
(fixatives) that extend the repellent effect by slowing the
evaporation of volatile repellent actives [20]. The studies
reported here were designed to measure whether such a
repellent, containing lower amounts of actives than
reported in previous studies, could prove its efficacy
against malaria vectors and other mosquitoes at a much-
reduced cost per application.
Methods
Study Site A
The field test was conducted near the Port of Champerico
(091°55'W,14°18'N) on the Pacific coast of Guatemala,
in June 2005. The estuaries and mangrove swamps that
characterize the area are fed by rivers that descend from
nearby volcanoes around Quezaltenango. The tests were
conducted on a local finca – a farm where cattle are raised.
The finca has a large permanent lagoon and swamp area
that is a known An. albimanus breeding site. As An. albi-
manus feeds preferentially on cattle [21] it was ensured
that livestock were enclosed 50 meters behind the volun-
teers, so that host-seeking mosquitoes emerging from the
breeding site and attracted by the animal odours, would
first encounter the collectors.
Study site B
The trial took place outside of Zungarococha, a small vil-
lage near Iquitos, the capital of Loreto, Peru (3.8° S 73.2°
W). It was staged in late February 2006 in order to coin-
cide with high An. darlingi populations, but while malaria
transmission remained low. The region is lowland tropi-
cal forest with two tributaries of the Amazon River flowing
through: the Nanay to the north, and the Itaya to the
south. The volunteers collected mosquitoes in a sparsely
wooded area that was situated between a group of houses
and a lake, or cocha, fed by the river that is a permanent
breeding site for An. darlingi.
Test Repellents. Study A
The following repellent formulations (% by volume) were
used: (1) C15 containing 15% PMD (derived by acid
modification of Corymbia citriodora; CAS: 42822-86-6;
Chemian Technology Ltd), with LG (distilled from Cym-
bopogon citratus; CAS: 8007-02-1 The Essential Oil Com-
pany Ltd.), filler and fixative; (2) T15: 15% PMD (derived
by acid modification of Citronellal and recovery with aro-
matic hydrocarbons; CAS 42822-86-6; Takasago Interna-
tional Corporation), with LG, filler and fixative (patent
pending); (3) T20: 20% PMD (Takasago International
Corporation), with LG, filler and fixative; (4) positiveMalaria Journal 2007, 6:101 http://www.malariajournal.com/content/6/1/101
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control: 15% DEET (N, N-diethyl-meta-toluamide, CAS
134-62-3; Sigma Aldridge) in ethanol; (5) negative con-
trol: filler mix.
Test Repellents. Study B
Slightly modified repellent formulations (% by weight)
were used: (1) PMD/LG containing 16% PMD (Takasago
International Corporation), with LG (Berje), filler and fix-
ative (patent pending); (2) positive control: 20% DEET
(Sigma Aldridge) in ethanol (Sigma Aldridge); (3) nega-
tive control: 20% mineral oil (ExxonMobil Corporation)
in ethanol.
Test Procedures. Study A and B
Both studies were controlled, double-blinded, Latin-
square designs that utilized human-landing catches from
treated or untreated volunteers in order to measure repel-
lency. All solutions were placed in unmarked containers
labelled by code. On any one night, human volunteers
had both lower legs treated with either the PMD/LG can-
didate repellents or a positive or negative control at a rate
of 0.002 ml/cm2 between the ankle and the knee. Volun-
teers' leg length and circumference were measured to cal-
culate surface area, and the correct dose of treatment was
measured using a micropipette. Repellent was then
applied using a latex glove to minimize absorption of
material by the hand of the volunteer. During the human-
landing catches, the volunteers wore shorts to the knee,
work boots, and a loose bug jacket (ProBuy) to ensure that
blood-seeking mosquitoes had access only to their lower
legs. After midday, volunteers did not smoke, consume
alcohol, or use soap when washing. This was intended to
minimize variation in their headspace kairomones
[22,23].
The designated locations within the field sites were 10 m
from each other and a minimum of 20 m from alternate
sources of kairomones such as houses and livestock. As
insect repellents act over a distance of less than a meter,
and the maximum distance of host attraction of a single
human to mosquitoes is 10 m [24], this design minimizes
the "relativity effect" wherein insects must choose
between two hosts simultaneously. Mosquitoes were col-
lected as soon as they landed on the exposed lower legs of
the volunteers, but before probing of the skin com-
menced, using a mouth aspirator, flashlight, and collec-
tion vessel designed for this purpose. Collection vessels
were changed each hour to provide hourly measures of
repellence. Umbrellas were also provided to protect the
volunteers from any rain showers that might wash away
their repellent.
Test Procedures. Study A
The three repellents and two controls were applied to the
five volunteers at 14.30 h, and human-landing catches
were performed at the field site for one hour before and
one hour after sunset (1730–1930 h), when the evening
mosquito biting is at its peak as shown by preliminary
human-landing catches. The times chosen allowed an
assessment of the protection afforded by the repellent
over five hours while exposing volunteers to bites for only
two hours. This helped minimize exposure and risk to the
collectors. The study was a balanced 5 × 5 Latin-square
design that required each volunteer to test each treatment
five times over a period of 25 nights. Every evening, each
individual was allocated one of five treatments, and sat in
one of five allocated positions. Consequently, the volun-
teers changed position every five days.
Test Procedures. Study B
The repellent and two controls were applied at 16.00 h,
and man-landing collections were performed in the field,
between 18.00 and 22.00 h, as this is the time of peak An.
darlingi activity in the area. The times chosen allowed an
assessment of the protection afforded by the repellent to
be made for a period of six hours while exposing volun-
teers to bites for only four hours. This helped minimize
exposure and risk to the collectors. The volunteers took a
15-minute break between 20.00 and 20.15 h. The study
was a 3 × 3 balanced Latin-square design that required
each volunteer to test each treatment three times over a
period of nine nights, with volunteers changing positions
every third night. Due to unforeseen circumstances, one of
the volunteers was replaced after four nights, and this was
factored into the statistical analysis.
Ethical Issues
All volunteers were experienced at conducting man-land-
ing catches. A form outlining procedure was given to the
volunteers to ensure that they had full understanding of
the potential risks of a study of this kind. In addition, each
was given a chloroquine (Guatemala) or mefloquine
(Peru) prophylaxis in accordance with WHO guidelines.
Full ethical approval was obtained from Universidad del
Valle, Guatemala (Study A); and from London School of
Hygiene and Tropical Medicine Ethics Board and Instituto
Nacional de Salud, Peru (Study B).
Statistical Analysis
Mosquitoes were maintained overnight and killed by
cooling prior to identification the following morning.
Data were normalized after transformation with natural
log (x+1), verified by Anderson-Darling Normality Test,
and were analysed with General Linear Model (GLM)
using SPSS 13 for Windows. The model measured the
effect of position, individual, hour and treatment (as fixed
factors) and day (as a random factor), on the transformed
mosquito counts. Further post hoc testing of individual
variables was performed using a Tukey's Honestly Signifi-
cant Different test (Tukey's HSD).Malaria Journal 2007, 6:101 http://www.malariajournal.com/content/6/1/101
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Results
Study A
In 25 nights, 6,140 mosquitoes were captured comprising
55.6% Psorophora varipes (Coquillett) and 24.8% Aedes
ochlerotatus taeniorhynchus. The average number of mos-
quito landings on the negative control was 108 per per-
son/hour and there was no significant difference in hourly
numbers of landings in this treatment (F = 0.896, d.f. = 1,
p = 0.345).
Each of the four repellents provided excellent protection
from host-seeking mosquitoes, and the PMD/LG repel-
lents provided >97% protection up to five hours after
application, with T15 and T20 providing 99% protection.
DEET (15%) provided 92% (Table 1). GLM analysis
showed that there was a significant difference between the
four repellents and the negative control, and between
DEET and the three PMD based repellents; although there
was no significant difference between the three PMD/LG
repellents (Tukey's HSD, p < 0.0001) (Table 1). Sources of
error in the experimental design were also investigated.
There was no significant difference between the collection
positions within the field site (F = 2.149, d.f. = 4, p =
0.76), although individuals varied significantly in their
mean attractiveness to mosquitoes/collection ability (F =
6.73, d.f. = 4, p < 0.0001).
Study B
In nine nights, 2,358 mosquitoes were captured, of which
86% were An. darlingi. The average number of landings on
the negative control was 46.28 per person/hour. There
was no significant difference in the hourly number of
mosquitoes captured from the control (F = 1.167, d.f. = 3,
p = 0.326), or An. darlingi (F = 1.667, d.f. = 3, p = 0.179)
which indicates that the repellents' efficacy did not signif-
icantly decline during the six hours of the test.
The PMD/LG repellent significantly outperformed DEET,
providing an average of 95% protection six hours after
application (F = 128.8, d.f. = 2, p < 0.0001) (Table 2). In
contrast, 20% DEET provided an average of 64% protec-
tion over the duration of the trial. Sources of bias were
investigated and there was no difference in the number of
mosquitoes captured in the three positions within the
field (F = 0.87, d.f. = 2, p = 0.422) or individual variation
in attractiveness to mosquitoes/collection ability (F  =
1.492, d.f. = 2, p = 0.230).
Discussion and Conclusion
In both field trials, the PMD/LG repellents with fixatives
showed excellent efficacy against a broad range of mos-
quito species, with greater than expected longevity for a
15% PMD formulation. Also, in these trials the PMD/LG
repellents showed greater efficacy than corresponding
doses of DEET. This is an important point, as several other
studies have shown PMD to have longevity similar to [17],
or lower than [25], a corresponding dose of DEET. During
a 2001 Bolivian field trial against An. darlingi where the
biting pressure was 75 mosquito landings per person/
hour, a repellent containing 30 % PMD in ethanol pro-
vided 97 % protection, and 15% DEET provided 85% pro-
tection for four hours after application [17]. However, in
the current Study A, the repellent containing half that con-
centration of PMD (T15) provided 99% protection for five
hours after application with a biting pressure of 108 mos-
quitoes per person/hour, compared to 92% for 15%
DEET. In Study B, a repellent with 16% PMD provided
95% protection for six hours after application, compared
to 64% protection for 20% DEET.
It may be inferred from this that the addition of fixatives
to the repellents tested in Guatemala and Peru slowed the
release of repellent volatiles, thereby extending the repel-
lents' duration and lowering its cost. Additionally,
because PMD is the most costly ingredient in the repel-
lent, the savings realized by a reduction in PMD content
from 30% to 15% have reduced the cost of this disease
prevention tool even more. There is much evidence that
the indigenous poor are less likely to purchase ITNs and
repellents, and more likely to rely upon cheaper, less effec-
tive methods of personal protection [26]. Therefore, mak-
Table 1: Efficacy of 4 repellent formulations tested 4 and 5 hours 
after application during Study A in Guatemala
Hours post application
Treatment 4 5 Mean 95 % C.I.
Filler mix 
control
AM 115.52 100.48 108.00 55.13 – 96.39
WM 79.83 66.64 72.74a
% P -- -- --
C15 AM 1.28 5.04 3.16 0.46 – 01.38
WM 0.64 1.40 0.96b
% P 98.89 94.98 97.07
T15 AM 1.36 1.44 1.40 00.43 – 01.17
WM 0.79 0.72 0.76b
% P 98.82 98.57 98.70
T20 AM 0.84 1.84 1.34 0.28 – 00.97
WM 0.43 0.77 0.59b
% P 99.27 98.17 98.76
15 % DEET AM 6.08 11.72 8.90 2.68 – 06.38
WM 3.63 4.87 4.21c
% P 94.74 88.34 91.76
AM = arithmetic mean mosquito landings per person hour.
WM = William's mean mosquito landings per person hour. Means 
followed by different letters are significantly different.
% P = Percentage protection i.e. 100 - ((mosquito landings on 
treatment ÷ mosquito landings on control) × 100).Malaria Journal 2007, 6:101 http://www.malariajournal.com/content/6/1/101
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ing the repellent available at the lowest cost possible
could enhance user acceptance.
The potential benefit of this portable protection to anti-
malaria campaigns in the Americas can be seen in the eco-
nomics of the 1998 malaria epidemic in Peru. It has been
estimated that the total cost of treating malaria that year
was $190 per individual case [27]. That includes all asso-
ciated state health expenses and the costs to the family for
treatment, lost income, and death. Adjusted for inflation,
that is approximately $250 in 2007. However, the esti-
mated annual cost per person for the repellent interven-
tion (coverage during the 7-month transmission season at
$0.024/day) is $5.00. That is 2% of the estimated total
cost of treatment today. Consequently, the PMD/LG
repellent may be an excellent candidate for incorporation
into existing vector control strategies.
If such economies could be achieved in Peru, while reduc-
ing the disease burden from malaria, this model might be
applicable to other regions where early evening biting is
problematic. Essentially, the model for "repelling"
malaria proposes the following: where the crepuscular
feeding behavior of the most significant malaria vectors is
already established, or where it may be shifting to early
evening biting or outdoor resting [28] (from selection due
to IRS and/or ITN use), it may be possible to achieve a
reduction of 60% in malaria cases [13]. This could be
achieved by saturation of at-risk communities (to avoid
diversion of malaria vectors to non-users) with high-effi-
cacy LCRs that are affordable and aromatically attractive
to the indigenous poor. Combined with ITNs, the reduc-
tion could be substantially greater.
A five-month Phase 3 study, currently under way in the
Peruvian Amazon, is providing an opportunity to meas-
ure the parameters of this model on 16 population clus-
ters. With 3,300 subjects divided into three cohorts
(Repellent Only, Repellent + ITNs, and No Intervention),
this community-wide study marks the first time that the
effect of a Repellent Only intervention on malaria rates
has been measured in a discrete population group in the
tropics. If the LCR's demonstrated capacity to repel
malaria vectors leads to a measurably significant reduc-
tion in the infection rate, the Puerta del Cielo Foundation
will begin distributing repellents and treated bednets at
cost to poor malaria-endemic communities throughout
the Peruvian Amazon.
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